Cite
[The Efficacy of Amrubicin Therapy as a Second Line Treatment in Patients with Small Cell Carcinoma of the Prostate : A Case Report]
MLA
Kaori, Ozawa, et al. “[The Efficacy of Amrubicin Therapy as a Second Line Treatment in Patients with Small Cell Carcinoma of the Prostate : A Case Report].” Hinyokika Kiyo. Acta Urologica Japonica, vol. 66, no. 4, June 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........7eb5554a11a1299d321015a6e3eadc08&authtype=sso&custid=ns315887.
APA
Kaori, O., Kazuya, Y., Hiroto, K., Daiki, K., Manabu, T., Koji, I., Keita, N., Kiyohisa, O., & Takuya, K. (2020). [The Efficacy of Amrubicin Therapy as a Second Line Treatment in Patients with Small Cell Carcinoma of the Prostate : A Case Report]. Hinyokika Kiyo. Acta Urologica Japonica, 66(4).
Chicago
Kaori, Ozawa, Yuhara Kazuya, Kotaka Hiroto, Kato Daiki, Takai Manabu, Iinuma Koji, Nakane Keita, Okamoto Kiyohisa, and Koie Takuya. 2020. “[The Efficacy of Amrubicin Therapy as a Second Line Treatment in Patients with Small Cell Carcinoma of the Prostate : A Case Report].” Hinyokika Kiyo. Acta Urologica Japonica 66 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........7eb5554a11a1299d321015a6e3eadc08&authtype=sso&custid=ns315887.